Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Zhejiang Hisoar Pharmaceutical Co., Ltd.
—
Zhejiang Hisoar Pharmaceutical Co., Ltd. is led by CEO Guorui Xu, employs 2,736 people, headquartered in Taizhou, CN, publicly traded since 2006.
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) stock trades at $5.84 with a market capitalization of $8.85B. The stock is valued at a negative price-to-earnings (P/E) ratio of -49.18, reflecting a net loss over the last twelve months, price-to-book of 2.15, price-to-sales of 4.52. Over the past 52 weeks the stock has ranged between $4.87 and $9.09, and currently trades 35.8% below its 52-week high.
On profitability, Zhejiang Hisoar Pharmaceutical Co., Ltd. generates a return on equity (ROE) of -3.44% (negative, reflecting a net loss), an operating margin of -5.06%, a net profit margin of -8.64%.
Official website: www.hisoar.com
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) — frequently asked questions
What is Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) stock price today?
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) is currently trading at $5.84, down 2.34% today.
What is 002099.SZ P/E ratio?
Zhejiang Hisoar Pharmaceutical Co., Ltd.'s P/E ratio is -49.18. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 002099.SZ return on equity (ROE)?
Zhejiang Hisoar Pharmaceutical Co., Ltd.'s return on equity (ROE) is -3.44%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Zhejiang Hisoar Pharmaceutical Co., Ltd.'s market cap?
Zhejiang Hisoar Pharmaceutical Co., Ltd. has a market capitalization of $8.85B.
Does 002099.SZ pay a dividend?
Zhejiang Hisoar Pharmaceutical Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 002099.SZ carry?
Zhejiang Hisoar Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 0.27. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 002099.SZ's profit margin?
Zhejiang Hisoar Pharmaceutical Co., Ltd. reports a net profit margin of -8.64% — the share of revenue left after every cost, including tax and interest.
What sector is 002099.SZ in?
Zhejiang Hisoar Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002099.SZ listed on?
Zhejiang Hisoar Pharmaceutical Co., Ltd. trades on SHZ under the ticker 002099.SZ.
What is 002099.SZ's 52-week range?
Over the last year Zhejiang Hisoar Pharmaceutical Co., Ltd. has traded between $4.87 and $9.09.
Related — Stocks
Popular Stocks
Screens 002099.SZ currently matches
On the figures above, Zhejiang Hisoar Pharmaceutical Co., Ltd. passes the filters for 6 of our ready-made screens, among them Low Debt Stocks, Stocks Under $10, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.